Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia
Authors
Keywords
-
Journal
CLINICAL ENDOCRINOLOGY
Volume 81, Issue 4, Pages 488-497
Publisher
Wiley
Online
2014-07-09
DOI
10.1111/cen.12546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose Sensing in the Peritoneal Space Offers Faster Kinetics Than Sensing in the Subcutaneous Space
- (2014) D. R. Burnett et al. DIABETES
- Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
- (2014) Peter R van Dijk et al. BMC Endocrine Disorders
- Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion
- (2013) Christina A. Hedman et al. CLINICAL ENDOCRINOLOGY
- Effect of i.p. insulin administration on IGF1 and IGFBP1 in type 1 diabetes
- (2013) P R van Dijk et al. Endocrine Connections
- Adiponectin Dysregulation and Insulin Resistance in Type 1 Diabetes
- (2012) Rocio I. Pereira et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Artificial Pancreas: Past, Present, Future
- (2011) Claudio Cobelli et al. DIABETES
- Achieved Levels of HbA1c and Likelihood of Hospital Admission in People With Type 1 Diabetes in the Scottish Population: A study from the Scottish Diabetes Research Network Epidemiology Group
- (2011) L. Govan et al. DIABETES CARE
- A Recent Survey Confirms the Efficacy and the Safety of Implanted Insulin Pumps During Long-Term Use in Poorly Controlled Type 1 Diabetes Patients
- (2011) Pauline Schaepelynck et al. Diabetes Technology & Therapeutics
- Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes
- (2011) C. Forsblom et al. JOURNAL OF INTERNAL MEDICINE
- Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
- (2010) S. J. Logtenberg et al. DIABETES CARE
- Lipid disorders in type 1 diabetes
- (2009) B. Vergès DIABETES & METABOLISM
- Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
- (2009) S. J. Logtenberg et al. DIABETES CARE
- Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery: Feasibility study testing a new model for the artificial pancreas
- (2009) E. Renard et al. DIABETES CARE
- A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion
- (2009) A. Liebl et al. DIABETES OBESITY & METABOLISM
- Reversible Focal Hepatic Steatosis in Type 1 Diabetic Patients Treated With Intraperitoneal Insulin Implantable Pump Therapy
- (2008) L. Meyer et al. DIABETES CARE
- The Role of IGF-system in Vascular Insulin Resistance
- (2008) H. Arnqvist HORMONE AND METABOLIC RESEARCH
- Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump
- (2008) Jan Willem Haveman et al. LANGENBECKS ARCHIVES OF SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started